Opposite regulation of Gax homeobox expression by angiotensin II and C- type natriuretic peptide

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 381-387

  Yamashita, Jun ^b   Itoh, Hiroshi ^a   Ogawa, Yoshihiro ^b   Tamura, Naohisa ^b   Takaya, Kazuhiko ^b   Igaki, Toshio ^b   Doi, Kentaro ^b   Chun, Tae Hwa ^b   Inoue, Mayumi ^b   Masatsugu, Ken ^b   Nakao, Kazuwa ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

angiotensin II; gene regulation; growth; growth arrest specific homeobox; homeobox; natriuretic peptides; vascular smooth muscle cells

Indexed keywords

8 BROMO CYCLIC AMP; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR RECEPTOR; CANDESARTAN; COMPLEMENTARY DNA; CYCLIC GMP; ENDOTHELIUM DERIVED RELAXING FACTOR; HOMEODOMAIN PROTEIN; MESSENGER RNA; NATRIURETIC PEPTIDE TYPE C; PLATELET DERIVED GROWTH FACTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CELL CYCLE; CONTROLLED STUDY; DNA LIBRARY; GENE EXPRESSION REGULATION; HOMEOBOX; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0031026514     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.381     Document Type: Article

References (50)

1. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
2. Chamley-Campbell J, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev. 1979;59:1-61.
3. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res. 1986;58:427-444.
4. Dilley RJ, McGeachie JK, Prendergast FJ. A review of the proliferative behaviour, morphology and phenotypes of vascular smooth muscle. Atherosclerosis. 1987;63:99-107.
5. Barja F, Coughlin C, Belin D, Gabbiani G. Actin isoform synthesis and mRNA levels in quiescent and proliferating rat aortic smooth muscle cells in vivo and in vitro. Lab Invest. 1986;55:226-233.
6. Suga S, Nakao K, Kishimoto I, Hosoda K, Mukoyama M, Arai H, Shirakami G, Ogawa Y, Komatsu Y, Nakagawa O, Hama N, Imura H. Phenotype-related alternation in expression of natriuretic peptide receptors in aortic smooth muscle cells. Circ Res. 1992;71:34-39.
7. Ross R, Glomset JA. Atherosclerosis and the arterial smooth muscle. Science. 1973;180:1332-1339.
8. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest. 1988;58:249-261.
9. Nilsson J. Growth factors and the pathogenesis of atherosclerosis. Atherosclerosis. 1986;62:185-189.
10. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
11. 1 transition in vascular smooth muscle cells. Mol Cell Biol. 1993;13:3722-3733.
12. Weir L, Chen D, Pastore C, Isner JM, Walsh K. Expression of Gax, a growth arrest homeobox gene, is rapidly downregulated in the rat carotid artery during the proliferative response to balloon injury. J Biol Chem. 1995;270:5457-5461.
13. Walsh K, Guo K, Suzuki E, Smith R, Andres V. Cell cycle control by the Gax homeobox protein in vascular smooth muscle cells. Circulation. 1994;4(suppl I):I-635. Abstract.
14. Gibbons GH, Dzau VJ. Molecular therapies for vascular diseases. Science. 1996;272:689-693.
15. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993;91:2268-2274.
16. Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest. 1990; 86:1690-1697.
17. Furuya M, Yoshida M, Hayashi Y, Ohnuma N, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1991;177:927-931.
18. Chinkers M, Garbers DL. Signal transduction by guanylyl cyclases. Annu Rev Biochem. 1991;60:553-575.
19. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β: possible existence of vascular natriuretic peptide system. J Clin Invest. 1992;90:1145-1149.
20. Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, Goeddel DV. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science. 1991;252:120-123.
21. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, Inouye K, Imura H. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology. 1992;130:229-239.
22. Itoh H, Nakao K. Antagonism between the vascular renin-angiotensin and natriuretic peptide systems in vascular remodelling. Blood Press. 1994;3(suppl 5):49-53.
23. Nakao K, Morii N, Itoh H, Yamada T, Shiono S, Sugawara A, Saito Y, Mukoyama M, Arai H, Sakamoto M, Imura H. Atrial natriuretic polypeptide in brain: implication of central cardiovascular control. J Hypertens. 1986;4(suppl 6):S492-S496.
24. Kambayashi Y, Nakajima S, Ueda M, Inouye K. A dicarba analog of β-atrial natriuretic peptide (β-ANP) inhibits guanosine 3′,5′-cyclic monophosphate production induced by α-ANP in cultured rat vascular smooth muscle cells. FEBS Lett. 1989;248:28-34.
25. Owens GK, Thompson LG. Expression of smooth muscle-specific isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol. 1986;102:343-352.
26. Komatsu Y, Itoh H, Suga S, Ogawa Y, Hama N, Kishimoto I, Nakagawa O, Igaki T, Doi K, Yoshimasa T, Nakao K. Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells: role of the vascular natriuretic peptide system in vascular growth inhibition. Circ Res. 1996;78:606-614.
27. Kawamura M, Terashita Z, Okuda H, Imura Y, Shino A, Nakao M, Nishikawa K. TCV-116, a novel angiotensin II receptor antagonist, prevents intimai thickening and impairment of vascular function after carotid injury in rats. J Pharmacol Exp Ther. 1993;266:1664-1669.
28. Griendling KK, Rittenhouse SE, Brock TA, Ekstein LS, Gimbrone MA, Alexander RW. Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J Biol Chem. 1986;261:5901-5906.
29. Brock TA, Alexander RW, Ekstein LS, Atkinson WJ, Gimbrone MAJ. Angiotensin increases cytosolic free calcium in cultured vascular smooth muscle cells. Hypertension. 1985;7(suppl I):I-105-I-109.
30. Griendling KK, Tsuda T, Berk BC, Alexander RW. Angiotensin II stimulation of vascular smooth muscle. J Cardiovasc Pharmacol. 1989;14:527-533.
31. Taubman MB, Berk BC, Izumo S, Tsuda T, Alexander RW, Nadal-Ginard B. Angiotensin II induces c-fos mRNA in aortic smooth muscle. J Biol Chem. 1989;264:526-530.
32. Itoh H, Pratt RE, Dzau VJ. Interaction of atrial natriuretic polypeptide and angiotensin II on protooncogene expression and vascular cell growth. Biochem Biophys Res Commun. 1991;176:1601-1609.
33. Molloy CJ, Taylor DS, Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J Biol Chem. 1993;268:7338-7345.
34. Duff JL, Berk BC, Corson MA. Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat smooth muscle cells. Biochem Biophys Res Commun. 1992;188:257-264.
35. Tsuda T, Kawahara Y, Ishida Y, Koide M, Shii K, Yokoyama M. Angiotensin II stimulates two myelin basic protein/microtubule-associated protein 2 kinases in cultured vascular smooth muscle cells. Circ Res. 1992;71:620-630.
36. Darnell JE, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415-1421.
37. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature. 1995;375:247-250.
38. Inui H, Kitami Y, Tani M, Kondo T, Inagami T. Differences in signal transduction between platelet-derived growth factor (PDGF) α and β receptors in vascular smooth muscle cells. J Biol Chem. 1994; 269:30546-30552.
39. Linseman DA, Benjamin CW, Jones DA. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells. J Biol Chem. 1995;270:12563-12568.
40. Gorski DH, Walsh K. Mitogen-responsive nuclear factors that mediate growth control signals in vascular myocytes. Cardiovasc Res. 1995;30:585-592.
41. Kariya K, Kawahara Y, Araki S, Fukuzaki H, Takai Y. Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis. 1989;80:143-147.
42. Doi K, Itoh H, Ikeda T, Hosoda K, Ogawa Y, Igaki T, Yamashita J, Chun TH, Inoue M, Tamura N, Takaya K, Masuda I, Saito Y, Yoshimasa T, Matsuda K, Ban T, Nakao K. Induction of growth arrest at G1 phase of vascular smooth muscle cells through cGMP cascade: effects of adenovirus-mediated overexpression of C-type natriuretic peptide. American Heart Association 50th Annual Fall Conference and Scientific Sessions, 1996. Abstract.
43. Needleman P, Adams SP, Cole BR, Currie MG, Geller DM, Michener ML, Saper CB, Schwartz D, Standaert DG. Atriopeptins as cardiac hormones. Hypertension. 1985;7:469-498.
44. Cantin M, Genest J. The heart and the atrial natriuretic factor. Endocr Rev. 1985;6:107-127.
45. Suh E, Traber PG. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol. 1996;16:619-625.
46. Desmouliére A, Rubbia-Brandt L, Gabbiana G. Modulation of actin isoform expression in cultured arterial smooth muscle cells by heparin and culture conditions. Arterioscler Thromb. 1991;11:244-253.
47. Majesky MW, Giachelli CM, Reidy MA, Schwartz SM. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ Res. 1992;71:759-768.
48. Boerth NJ, Lincoln TM. Expression of the catalytic domain of cyclic GMP-dependent protein kinase in a baculovirus system. FEBS Lett. 1994;342:255-260.
49. Inoue A, Hiruma Y, Hirose S, Yamaguchi A, Furuya M, Tanaka S, Hagiwara H. Stimulation by C-type natriuretic peptide of the differentiation of clonal osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun. 1996;221:703-707.
50. Nabel EG. Gene therapy for cardiovascular disease. Circulation. 1995;91:541-548.